Colchicine in HFpEF

Summary

Colchicine in HFpEF is a clinical trial^[1].

Key Facts

• Colchicine in HFpEF is in the country of Canada^[2].
• Colchicine in HFpEF's instance of is recorded as clinical trial^[3].
• Colchicine in HFpEF's start time is recorded as +2022-06-17T00:00:00Z^[4].
• Colchicine in HFpEF's end time is recorded as +2024-05-31T00:00:00Z^[5].
• Colchicine in HFpEF's main subject is recorded as heart failure^[6].
• Colchicine in HFpEF's number of participants is recorded as {'unit': '1', 'amount': '+426'}^[7].
• Colchicine in HFpEF's title is recorded as A Biomarker Study Assessing the Effects of Colchicine on Inflammation and Extra-Cellular Matrix Turnover in Patients With Heart Failure and Preserved Ejection Fraction.^[8].
• Colchicine in HFpEF's short name is recorded as COLpEF^[9].
• Colchicine in HFpEF's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}^[10].
• Colchicine in HFpEF's ClinicalTrials.gov ID is recorded as NCT04857931^[11].
• Colchicine in HFpEF's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[12].
• Colchicine in HFpEF's research intervention is recorded as colchicine alkaloids^[13].
• Colchicine in HFpEF's research intervention is recorded as disease-modifying antirheumatic drug^[14].
• Colchicine in HFpEF's research intervention is recorded as tubulin modulators^[15].
• Colchicine in HFpEF's research intervention is recorded as mitotic inhibitor^[16].
• Colchicine in HFpEF's research intervention is recorded as mitosis modulators^[17].
• Colchicine in HFpEF's research intervention is recorded as mechanism of action^[18].
• Colchicine in HFpEF's research intervention is recorded as alkylating antineoplastic agent^[19].
• Colchicine in HFpEF's clinical trial phase is recorded as phase II clinical trial^[20].
• Colchicine in HFpEF's research subject recruitment status is recorded as recruiting^[21].
• Colchicine in HFpEF's study type is recorded as interventional study^[22].